It is found that in men with confirmed inflammatory processes of the prostate, the risk of getting cancer is 1.78 times higher than that of men without proven prostatitis. Therefore, complex therapy of chronic prostatitis should be designed in the necessary full volume, preferably with the restoration of local immunity and systemic harmonization of immune homeostasis. To accomplish these tasks, a unique preparation of exogenous peptides, ArecurĀ®, has been created.
Harmonization of immune homeostasis with the help of exogenous peptides creates conditions for increasing the effectiveness of treatment of chronic infectious and inflammatory processes of the prostate gland.